Davis A Brian Insider Trades

Insider Trading History

Track insider trading activity for Davis A Brian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acasti Pharma
Acasti Pharma ACST
Director
Holding Value $75.8k 22,500 shares
Last Trade
Dec 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.9k 22,500 shares
$2.13
$3.37
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $75.7k 12,900 shares
Last Trade
Jun 04, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.5k 5,000 shares
$9.89
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $382k 65,000 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$931k 65,000 shares
$14.32
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $46.4k 7,900 shares
Last Trade
Aug 13, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.3k 7,900 shares
$6.24
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $323k 55,000 shares
Last Trade
Feb 27, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$650k 55,000 shares
$11.81
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
Chief Financial Officer
Holding Value $734k 125,000 shares
Last Trade
Oct 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.83M 125,000 shares
$14.65
$5.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up